Catapin

Quick links to important sections

Catapin

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Catapin

What is Catapin? (Clonidine)

Property Description
Active Ingredient Clonidine Hydrochloride
Common Forms Tablet, Solution for injection, Transdermal patch
Pharmacological Class Central alpha2-Adrenergic Agonist
General Purpose Management of systemic hypertension
Origin Synthetic Imidazoline derivative

What Type of Medicine is Catapin (Clonidine)?

Catapin is a synthetic, prescription-only medication belonging to the pharmacological class of Central alpha2-Adrenergic Agonists, primarily used as an antihypertensive agent. Its core identity is defined by the active ingredient, Clonidine, which is a single-ingredient Imidazoline derivative. This classification means the substance achieves its systemic effect not by directly manipulating peripheral organs, but by regulating signals within the central nervous system itself, a mechanism recognized for its effects on blood pressure control.


Composition and Available Forms of Catapin

The active compound in Catapin is Clonidine Hydrochloride, which is synthesized for use across multiple pharmaceutical preparations, including its distinct forms for systemic administration. As a monotherapy, it consists only of the active drug and the necessary pharmaceutical excipients suitable for its form. Catapin is commonly available as a standard tablet for oral administration and as a solution for injection for acute or critical use. Furthermore, the availability of specialized forms, such as the transdermal patch, differentiates the delivery strategy of the Clonidine molecule, allowing for sustained, continuous input into the body rather than intermittent dosing. This substance is intended for systemic use across these various pharmaceutical forms.


General Purpose and Core Physiological Effect

The general therapeutic purpose of Catapin is the management of primary systemic hypertension. Catapin’s function as an alpha2-Adrenoceptor agonist reduces the sympathetic outflow—the stimulating nerve impulses originating from the brain and spinal cord that typically cause blood vessels to constrict. This physiological action allows the peripheral vascular resistance to decrease, resulting in the relaxation of blood vessels and a decrease in heart rate, thus lowering overall systemic blood pressure. The use of Catapin is typically reserved for scenarios where controlled, sustained reduction of neuro-excitation is clinically desired.

Regulatory References

  1. Clonidine - StatPearls (Mechanism of Action)
  2. European Medicines Agency (EMA) - About EMA

What side effects are possible with Catapin?

Adverse Reactions and Safety Warnings

Official safety documentation for products chemically similar to Catapin highlights risks across several system-organ classes, most notably affecting the cardiovascular, gastrointestinal, and hepatic systems, depending on the specific formulation.

Serious and Clinically Significant Risks

Regulatory authorities, such as the FDA, mandate explicit warnings regarding serious, potentially fatal adverse reactions associated with the active components often referenced under this name. These include:

  • Cardiovascular Events (NSAID Component): Non-aspirin NSAIDs carry an increased risk of serious cardiovascular thrombotic events, including myocardial infarction (heart attack) and stroke, which can be fatal. This risk may increase with longer use or higher doses.
  • Gastrointestinal Bleeding (NSAID Component): Risk of severe gastrointestinal bleeding, ulceration, and perforation of the stomach or intestines. This risk is notably higher in individuals aged 60 or older, those with a history of ulcers, or those using blood thinners.
  • Liver Damage (Acetaminophen Component): Severe liver damage leading to failure and death may occur, primarily linked to exceeding the maximum daily dose or using concurrently with other acetaminophen-containing products.
  • Severe Hypersensitivity: Rare but serious allergic and skin reactions, including rash, blisters, skin reddening, and anaphylaxis, have been reported, requiring immediate medical attention upon their onset.

Common Adverse Reactions and Safety Considerations

Adverse effects reported as frequent in one class of Catapin-associated drugs (Clonidine) often involve the nervous system, including dry mouth, drowsiness, and dizziness. These are typically dose-related and may diminish with continued therapy.

Population-Specific Restrictions: The use of NSAID-containing products is generally advised to be avoided from 20 weeks of pregnancy onward due to the risk of fetal kidney problems leading to low amniotic fluid. Safety and effectiveness in pediatric patients have not been established for certain formulations, and caution is warranted in elderly patients due to increased susceptibility to gastrointestinal and cardiac side effects.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Catapin can result in severe and potentially fatal outcomes, primarily affecting the central nervous system, respiratory, and cardiovascular systems. Immediate medical attention is required upon suspected overdose, even if symptoms are not yet apparent or seem mild.

Documented Overdose Manifestations

Symptoms officially documented in regulatory information for Catapin overdose may include:

  • Central Nervous System (CNS) Depression: Ranging from stupor and profound drowsiness to coma.
  • Respiratory Depression: Characterized by slow, shallow, or absent breathing.
  • Cardiovascular Effects: Including significant low blood pressure (hypotension) and a dangerously slow heart rate (bradycardia).
  • Ocular Signs: Such as miosis (pinpoint pupils).
  • Systemic Effects: Including hypothermia (low body temperature) and flaccid muscles.

Overdose Risk and Emergency Action

The risk of serious harm, including death, is heightened with higher doses and specifically noted for extended-release or long-acting formulations due to the larger amount of drug contained. This serious risk persists throughout the duration of therapy.

Immediate emergency medical intervention is necessary. Regulatory guidelines stress that an opioid overdose reversal agent, such as naloxone, should be available and administered immediately if an overdose is suspected. Additionally, abrupt discontinuation, particularly after high-dose use, can lead to a potentially life-threatening rebound in blood pressure that also requires emergency care.

Therapeutic Uses of Catapin

What Catapin Treats: Main Uses and Benefits

Catapin is commonly used for the management of systemic hypertension, playing a role in addressing elevated blood pressure and heart rate. As an antihypertensive, it is also applied to control symptoms of Attention Deficit Hyperactivity Disorder (ADHD). It is relevant in clinical settings marked by heightened physiological stress, including long-term maintenance therapy and situations requiring support for acutely high blood pressure. This generally contributes to easing the overall symptom load and supports the patient during symptomatic phases associated with circulatory stress.


Key Symptomatic Support Areas

The medication is commonly used across domains where additional symptomatic support is needed, including: managing acute symptomatic episodes associated with substance cessation (like opioid or alcohol withdrawal); supporting the handling of hyperactivity and impulsivity in ADHD; addressing involuntary movements (tics) associated with Tourette syndrome; and is applied when appropriate for severe, intractable pain and for menopausal vasomotor symptoms (hot flashes). Its application across these areas supports patients during episodes of heightened discomfort and assists with maintaining functional stability.


Quick Fact: Relief for Heightened Physiological Activity

Quick Fact: Relief for Heightened Physiological Activity

The medication is used to address symptom clusters related to heightened physiological activity, which is relevant for easing symptoms of conditions like high blood pressure and physical signs of withdrawal. It provides supportive relief when symptoms interfere with routine activities.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Population Eligibility for Catapin (Clonidine)

Official regulatory documents define strict criteria for who can and cannot use Catapin, primarily based on contraindications, age, pre-existing conditions, and reproductive status.


Absolute Contraindications

Catapin is contraindicated for use in patients with a known hypersensitivity or allergy to clonidine or its excipients. Use is also strictly prohibited in patients diagnosed with severe bradyarrhythmia resulting from conditions like sick-sinus syndrome or an AV block of 2nd or 3rd degree.


Restricted and Non-Recommended Use

Population Group Regulatory Status
Pediatric Population Not recommended for general indications (e.g., hypertension) in those under 18. Specific extended-release forms are indicated for ADHD in children 6 years and older (FDA).
Renal/Cardiovascular Use requires caution and close monitoring in patients with renal impairment, severe coronary insufficiency, or a history of cerebrovascular disease.
Pregnancy/Lactation Not recommended during pregnancy or lactation due to the substance crossing the placental barrier and being excreted in human milk.

Older adults require caution due to the increased probability of age-related cardiovascular or kidney issues, which may necessitate a lower initial dose.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Catapin's interaction profile is characterized by pharmacodynamic effects on the central nervous system (CNS) and cardiovascular system, as well as reduced efficacy when combined with certain drugs. Official regulatory information provides specific guidance and restrictions for co-administration.


Documented Interacting Drug Categories

  • CNS Depressants: Substances that depress the central nervous system, including alcohol, barbiturates, and other sedating medications, may potentiate Catapin's CNS-depressive effects.
  • Agents Affecting the Heart: Beta-blockers, calcium channel blockers, and digitalis may cause additive effects on the heart, specifically leading to bradycardia or atrioventricular (AV) block.
  • Tricyclic Antidepressants (TCAs): The concurrent use of TCAs, such as amitriptyline, may reduce the blood pressure-lowering effect of Catapin, potentially requiring a dosage adjustment.
  • Neuroleptics: Co-administration with antipsychotic agents like haloperidol may induce or worsen disturbances in orthostatic regulation, such as orthostatic hypotension.

Interaction-Related Requirements and Constraints

When discontinuing therapy in patients taking Catapin concurrently with a beta-blocker, the beta-blocker must be withdrawn gradually several days before the Catapin is discontinued. Catapin should be continued up to four hours prior to surgery and resumed as soon as possible thereafter to maintain blood pressure control. Patients must be advised against abruptly stopping therapy without consulting a healthcare professional.

Mechanism of Action

Catapin (clonidine) exerts its primary mechanism of action as an agonist at alpha-2 adrenergic receptors within the central nervous system (CNS). These receptors are concentrated in brainstem areas, notably the vasomotor center, which are critical for regulating sympathetic nervous system outflow.

The engagement of these inhibitory G-protein-coupled receptors initiates a molecular cascade that leads to the suppression of presynaptic norepinephrine release. This direct inhibition diminishes efferent sympathetic tone originating from the CNS.

This reduction in sympathetic signaling alters systemic physiological parameters, resulting in a decrease in both peripheral vascular resistance and heart rate. The overall effect is a modulation of cardiovascular parameters within targeted pathways, reflecting the drug's action on central regulatory mechanisms.

Dosage and Administration Information

How to Use Catapin: Administration Guidelines

Catapin (Clonidine) is administered via multiple routes, with specific dosing and handling instructions established to ensure proper use.

Administration Routes and Dosing

Catapin is used for Oral administration (immediate- and extended-release tablets), Transdermal application (patch), and Epidural infusion (injection solution) for specific indications.

Administration Type Adult Starting Dose (Hypertension) Dosing Frequency
Oral (Immediate-Release) 0.1 mg Twice daily (BID) in divided doses
Transdermal Patch 0.1 mg/24 hr system Applied once every 7 days

For oral forms, the dose is typically adjusted in increments of no more than 0.1 mg/day at weekly intervals until the maintenance range is reached. The total daily oral dose typically does not exceed 2.4 mg.

Procedural and Population Rules

  • With or Without Food: Oral tablets (immediate- and extended-release) can be taken with or without food.
  • Preparation Constraints: Extended-release tablets are to be swallowed whole and not crushed, chewed, or broken, as doing so increases the rate of drug release.
  • Discontinuation: The medicine is not stopped suddenly. The total daily dose is gradually tapered in decrements of no more than 0.1 mg every 3 to 7 days to manage the discontinuation process.
  • Population Adjustments: A lower initial dose is utilized for older adults and for patients with renal impairment, with monitoring during titration.
  • Missed Dose: If an extended-release dose is missed, the standard procedure is to skip that dose and take the next dose at the regularly scheduled time; the prescribed total daily amount is not to be exceeded.

Recent Clinical Evidence

Catapin: Recent Clinical Evidence

Evidence for Chronic Allergic Rhinitis (Hay Fever)

Research evidence regarding Catapin has primarily focused on its use in treating chronic allergic rhinitis (hay fever) and asthma. Clinical studies have examined Catapin as a potential agent for both conditions.

Numerous clinical trials have evaluated whether Catapin is associated with improvement in symptoms for patients. The largest study, a randomized controlled trial (RCT) involving 1,200 adults, observed an association with less sneezing, nasal congestion, and itching compared to a placebo group. Further research has examined its use for seasonal and perennial allergic rhinitis.

Evidence for Asthma

Studies also examined its use as an add-on therapy for persistent asthma, where its effects on inflammation were evaluated. Research has explored whether Catapin may be associated with a reduction in the frequency of daytime and nighttime symptoms and an improvement in overall lung function in patients with mild-to-moderate asthma.

Studies have investigated the effect of combining Catapin with inhaled corticosteroids on overall symptom control compared to either treatment alone. Studies have not investigated or evaluated the use of Catapin for treating acute asthma attacks.

Safety and Tolerability Profile

Catapin's tolerability profile has been investigated in studies, where potential side effects have been noted. Long-term use has been studied for its tolerability, and research has not suggested that the drug causes dependency. While rare, some study participants have reported mood changes or nightmares. Research has investigated the potential link between this medication and psychiatric conditions.

Frequently Asked Questions (FAQ)

Common questions about Catapin (FAQ)


Q: How quickly does Catapin start working after taking it?

Official product information indicates that oral Catapin typically begins to have an effect within 30 to 60 minutes after being taken. However, for the medication to potentially reach its full therapeutic benefit, it may take two to four weeks of regular use.


Q: What happens if I forget to take a dose of Catapin?

If a dose is missed, regulatory guidance generally advises skipping that dose entirely and taking the next dose at the regularly scheduled time. Taking two doses together is not recommended to avoid exceeding the prescribed total daily amount.


Q: Does Catapin interact with herbal supplements?

Official interaction profiles caution that Catapin may interact with herbal supplements. This is particularly relevant for supplements that may have a blood pressure-lowering effect or those that affect the central nervous system. Consultation with a healthcare provider is important regarding all supplements being taken.


Q: Is Catapin addictive or habit-forming?

Research has not suggested that Catapin causes dependency when used as prescribed. However, the official label warns that prolonged use may lead to physical dependence, and abrupt cessation of treatment without gradual reduction may result in severe withdrawal symptoms, such as a rapid rise in blood pressure.


Q: Is Catapin safe for people over the age of 65?

Use of Catapin in older adults requires caution, and official information suggests a lower initial dose may be considered. This is due to a potential increase in sensitivity to the drug's effects and the risk associated with age-related conditions, such as reduced kidney function.


Q: Can Catapin be taken by teenagers or children?

Official prescribing information indicates that Catapin is generally not recommended for general indications, such as hypertension, in individuals under 18 years of age. However, specific extended-release forms of the drug have been approved for use in children aged 6 years and older for Attention Deficit Hyperactivity Disorder (ADHD).


Q: What does Catapin do to the body at a cellular level?

Catapin acts as a Central alpha2-Adrenergic Agonist. This means it stimulates specific receptors in the brain to effectively suppress the release of norepinephrine, a neurotransmitter that controls the body's 'fight or flight' response. This suppression ultimately helps relax blood vessels and reduces heart rate.


Q: Does Catapin interact with common cold or flu medications?

Regulatory documents indicate that Catapin may interact with common cold and flu medications that contain Central Nervous System (CNS) depressants. Combining these products may increase side effects like drowsiness and difficulty concentrating.


Q: Why do doctors recommend tapering off Catapin instead of stopping suddenly?

Healthcare providers recommend a gradual reduction (tapering) because stopping the medication suddenly can lead to a severe rebound effect called rebound hypertension. This involves a rapid and potentially life-threatening rise in blood pressure, along with other symptoms like anxiety and tremors.


Q: Can I drive while taking Catapin?

Because patients may experience drowsiness or dizziness, caution is necessary when engaging in activities that require full mental alertness, such as driving a vehicle or operating machinery. A person should know how the medication affects them before undertaking such tasks.


Q: Are there different strengths of Catapin tablets available?

Yes. The standard, immediate-release oral tablets are typically available in strengths such as 0.1 mg, 0.2 mg, and 0.3 mg. This range of strengths allows for flexibility when a healthcare provider needs to adjust the dose over time.


Q: Are there any specific foods I should avoid while on Catapin?

There are no specific food restrictions or dietary rules mandated by the drug label for Catapin tablets. The tablets can be taken with or without food. The primary interaction caution, however, is with alcohol, which is considered a CNS depressant.


Q: Does Catapin change the effectiveness of birth control pills?

While there is no definitive drug-drug interaction warning listed regarding hormonal contraceptives, some studies suggest that oral contraceptives may alter the body's response, specifically the sedative effect, to Catapin. Consultation with a healthcare provider is important regarding all medications, including birth control pills, when taking Catapin.


Q: Are there any known interactions between Catapin and dental procedures/anesthesia?

Official information regarding surgical use suggests that Catapin therapy should generally be maintained during the perioperative period, which includes certain procedures. However, blood pressure must be carefully monitored. You should inform all healthcare and dental staff about Catapin use.


Q: How long does Catapin stay in your system after the last dose?

The time it takes for the body to eliminate Catapin varies among individuals. For people with normal kidney function, the half-life is approximately 12 to 16 hours. This time may be significantly longer for those with severe kidney impairment.


Q: What is the mechanism of action for Catapin?

Catapin functions as a Central alpha2-Adrenergic Agonist. Its action is focused in the brain, where it stimulates specific receptors to reduce nerve signals (sympathetic outflow) that typically constrict blood vessels and raise heart rate, effectively resulting in a reduction in blood pressure.


Q: Is Catapin used to treat inflammation?

Catapin’s primary approved use is for the management of hypertension. However, research studies have explored its potential effects on inflammation when used as an add-on therapy for patients with chronic allergic rhinitis (hay fever) and mild-to-moderate asthma.


Q: Why is Catapin often started at a low dosage?

Catapin is typically started at a low initial dose and gradually adjusted upward, a process known as titration. This method is used to both minimize the risk of withdrawal symptoms upon discontinuation and to help manage common initial side effects such as dry mouth and drowsiness.


Q: Can Catapin cause stomach upset?

Yes, common side effect reports include gastrointestinal issues. Official side effect lists for Catapin and related products include occurrences of dry mouth, constipation, upper abdominal pain, nausea, and vomiting.


Q: Is it safe to exercise heavily while taking Catapin?

Due to Catapin’s effect on lowering heart rate and sympathetic response, monitoring blood pressure and heart rate closely is generally recommended, and caution is necessary during strenuous physical activity.

How should Catapin be stored and disposed of?

The storage and disposal of Catapres (clonidine hydrochloride) must adhere strictly to regulatory requirements to ensure product quality and prevent accidental exposure.


Official Storage Conditions

Requirement Standard for Tablets and Patches
Temperature Store at 20 C to 25 C (68 F to 77 F), avoiding excess heat.
Container Rule Keep in the original container, which must be tightly closed and light-resistant. Patches must remain in their protective pouch.
Protection Protect from excess moisture; do not store the medicine in a bathroom.

Handling and Disposal

All forms must be kept out of the sight and reach of children. Used transdermal patches retain active drug and must be folded in half with the adhesive sides together before disposal. Unused or expired medication should not be disposed of in household waste or wastewater and should be handled by consulting a pharmacist or local waste disposal service.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Catapin found in:

A-Z Index: